Antibiotic drug resistance TB in India-Reference-Cited by-同舟云学术

Antibiotic drug resistance TB in India

Published:2022-01-15 Issue:4 Volume:8 Page:145-151
ISSN:2394-2789
Container-title:International Journal of Pharmaceutical Chemistry and Analysis
language:
Short-container-title:IJPCA

Author:

Gohil Chiragkumar J.¹,Patel Priyanka R.²,Gohil Jignakumari J.

Affiliation:

1. Gujarat Technological University, Ahmedabad , Gujarat, India

2. G

Abstract

Tuberculosis is a disease caused by bacteria spread from person to person through air. TB usually affects the lungs, but it can also affect other parts of the body, such as brain or kidney. Global surveillance has shown that drug resistant TB is widespread and is now a treat to tuberculosis control programs in many countries. This review describes treatment of tuberculosis and the drug resistance problem in India.

Publisher

IP Innovative Publication Pvt Ltd

Reference37 articles.

1. Gohil C J, Noolvi M N, Sen Patel C N, D J, Review of design approaches and clinical progress of MDM2 inhibitors.Int Res J Pharm 2021;11(1):1-7

2. World Health Organization. Global Tuberculosis Report..

3. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide.MMWR Morb Mortal Wkly Rep 2000;55(11):301-5

4. Gohil C J, Noolvi M N, Protein , Master Regulator of Apoptosis and its Application in Cancer Therapy.Int J Pharm Bio Arch 2019;10(3):154-64

5. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.Indian J Tuberc 2010;57(7):180-91

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism and management of antibiotic drug resistance tuberculosis;International Journal of Pharmaceutical Chemistry and Analysis;2022-10-15